Dare Bioscience, Inc. (DARE) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Dare Bioscience, Inc. on June 22, 2026. The filing serves as a Regulation FD disclosure to furnish a corporate presentation dated June 22, 2026, to securities market participants. The company is incorporated in Delaware and trades on the Nasdaq Capital Market under the symbol "DARE".
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to distribute a corporate presentation and does not contain audited financial statements or specific financial data points within the text provided.
Material Changes
No material changes to financial performance or operations are detailed in the text of this filing. The primary event reported is the release of a corporate presentation for investor relations purposes.
Guidance, Outlook, and Risks
The company intends to use the attached presentation (Exhibit 99.1) in meetings with market participants. The filing explicitly states that the information in the presentation is furnished and not "filed" for purposes of Section 18 of the Exchange Act, nor is it subject to the liabilities of that section. Consequently, specific guidance, outlook, or risk factors contained within the presentation are not incorporated by reference into this report.
Key Facts for Investor Verification
- Verify the contents of the corporate presentation (Exhibit 99.1) available on the company's investor relations website for specific operational updates or financial guidance.
- Note that the presentation materials are not legally "filed" with the SEC and are not subject to the same liability standards as the Form 8-K itself.
- Confirm the date of the presentation is June 22, 2026, as referenced in Item 7.01.